Published : Nov-2020
No. of Pages : 407
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Cardiac Marker Tests Overview
3 Products under Development
3.1 Cardiac Marker Tests - Pipeline Products by Stage of Development
3.2 Cardiac Marker Tests - Pipeline Products by Segment
3.3 Cardiac Marker Tests - Pipeline Products by Territory
3.4 Cardiac Marker Tests - Pipeline Products by Regulatory Path
3.5 Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
3.6 Cardiac Marker Tests - Ongoing Clinical Trials
4 Cardiac Marker Tests - Pipeline Products under Development by Companies
4.1 Cardiac Marker Tests Companies - Pipeline Products by Stage of Development
4.2 Cardiac Marker Tests - Pipeline Products by Stage of Development
5 Cardiac Marker Tests Companies and Product Overview
6 Cardiac Marker Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
List of Tables
Table 1: Cardiac Marker Tests - Pipeline Products by Stage of Development
Table 2: Cardiac Marker Tests - Pipeline Products by Segment
Table 3: Cardiac Marker Tests - Pipeline Products by Territory
Table 4: Cardiac Marker Tests - Pipeline Products by Regulatory Path
Table 5: Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Marker Tests - Ongoing Clinical Trials
Table 7: Cardiac Marker Tests Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Marker Tests - Pipeline Products by Stage of Development
Table 9: 3PrimeDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: PulsePredic Test - Product Status
Table 11: PulsePredic Test - Product Description
Table 12: A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Methionine Enzymatic Assay - Product Status
Table 14: Methionine Enzymatic Assay - Product Description
Table 15: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Alinity c Assay - D-Dimer - Product Status
Table 17: Alinity c Assay - D-Dimer - Product Description
Table 18: Alinity ci Assay - Cardiac Diseases - Product Status
Table 19: Alinity ci Assay - Cardiac Diseases - Product Description
Table 20: Alinity i Assay - Galectin-3 - Product Status
Table 21: Alinity i Assay - Galectin-3 - Product Description
Table 22: Alinity i Assay - STAT CKMB - Product Status
Table 23: Alinity i Assay - STAT CKMB - Product Description
Table 24: Alinity i Assay - STAT Myoglobin - Product Status
Table 25: Alinity i Assay - STAT Myoglobin - Product Description
Table 26: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Status
Table 27: ARCHITECT c16000 Integrated System - Galectin-3 Assay - Product Description
Table 28: ARCHITECT c4000 - Galectin-3 Assay - Product Status
Table 29: ARCHITECT c4000 - Galectin-3 Assay - Product Description
Table 30: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Status
Table 31: ARCHITECT c4000 System - High Sensitive Troponin-I Assay - Product Description
Table 32: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Status
Table 33: ARCHITECT c8000 Integrated System - Galectin-3 Assay - Product Description
Table 34: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Status
Table 35: ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Product Description
Table 36: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Status
Table 37: ARCHITECT ci16200 Integrated System - NT Pro BNP Assay - Product Description
Table 38: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Status
Table 39: ARCHITECT ci4100 Integrated System - Galectin-3 Assay - Product Description
Table 40: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Status
Table 41: ARCHITECT ci4100 Integrated System - NT Pro BNP Assay - Product Description
List of Figures
Figure 1: Cardiac Marker Tests - Pipeline Products by Stage of Development
Figure 2: Cardiac Marker Tests - Pipeline Products by Segment
Figure 3: Cardiac Marker Tests - Pipeline Products by Territory
Figure 4: Cardiac Marker Tests - Pipeline Products by Regulatory Path
Figure 5: Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
